LENZ Therapeutics, Inc. Common Stock (LENZ)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
LENZ Therapeutics, Inc. Common Stock (LENZ) is listed on Nasdaq, where it has traded since March 22, 2024.
- Listed On
- Nasdaq
- Listed Since
- March 22, 2024
- Employees
- 152
- Market Cap
- $123M
About LENZ Therapeutics, Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 140 institutions reported holding LENZ, with 34.7 million shares worth $197.3 million in aggregate. The largest reported holder was RA Capital Management,, with 4.2 million shares worth $23.7 million. Of the 5 largest holders listed below, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| RA Capital Management, | 4,178,823 | $24M | Unchanged |
| Alpha Wave Global | 3,612,211 | $21M | Unchanged |
| FMR | 3,558,905 | $20M | Reduced 1.08% |
| Versant Venture Management | 2,656,888 | $15M | Unchanged |
| BlackRock | 2,292,121 | $13M | Added 15.95% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is LENZ?
LENZ Therapeutics, Inc. Common Stock (LENZ) is listed on Nasdaq, where it has traded since March 22, 2024.
Who are the largest institutional holders of LENZ?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of LENZ were RA Capital Management,, Alpha Wave Global and FMR.
How many institutions own LENZ?
140 institutions reported a position in LENZ for the quarter ended June 30, 2026, worth $197.3 million in total.
Did institutions buy or sell LENZ last quarter?
Of the 5 largest reported holders, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for LENZ.
Every reported institutional holder, plus insider and congressional trades in LENZ, on SentiSense.